CSF1R and breast neoplasm: In addition, when macrophage recruitment is blocked with antagonists to colony stimulating factor 1 receptor (CSF1R) and in combination with paclitaxel, this treatment causes both an increase in primary breast tumor and lung metastasis as well as increased tumor suppression that was CD8+ CTL cytotoxic T cell-dependent [39].